In the present study, we provided further evidence that miR-181b-mediated TGFβR1 inactivation not only pulled down the TGF-β signaling but also inactivated PI3K/Akt pathway in NSCLC. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.